𝔖 Bobbio Scriptorium

✦ LIBER ✦

Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: No

✍ Scribed by G. J. HANKEY

Book ID: 109149083
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 87 KB
Volume: 3
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2005.01439.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is clopidogrel the antiplatelet drug of

Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: Yes

✍ H.-C. DIENER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Is Aspirin Still the Antiplatelet Drug o

Is Aspirin Still the Antiplatelet Drug of Choice for Patients with Peripheral Arterial Disease?

✍ M.I. Matsagas; I.A. Jagroop; D.P. Mikhailidis; G. Geroulakos 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PCV126 REDUCTION IN REHOSPITALIZATIONS A

PCV126 REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA

✍ EM Mahoney; K Wang; JP Bae; B Zhu; MD Marciniak; MB Effron; DJ Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Dietary supplementation with n -3 polyun

Dietary supplementation with n -3 polyunsaturated fatty acids, but not vitamin E, reduced the risk of mortality and morbidity after recent MI: Vitamin E had no effect on the risk of cardiovascular death, MI and stroke in patients at high risk for cardiovascular events but without LV dysfunction or HF

✍ Julie E. Buring 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 250 KB